A carregar...

Clinical Trial Transparency Is Up for Grabs: The FDA and Congress Are Expanding Public Access to Data

Years of complaints about poor access to information on “compassionate use” of experimental drugs and a lack of transparency in clinical trials are driving reform efforts by the National Library of Medicine, the Food and Drug Administration, and Congress.

Na minha lista:
Detalhes bibliográficos
Publicado no:P T
Autor principal: Barlas, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: MediMedia USA, Inc. 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495870/
https://ncbi.nlm.nih.gov/pubmed/26185404
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!